Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C

BACKGROUND: Clinicians often face dilemmas with decisions related to formulary choices when two similar drugs are simultaneously available in the market. We studied the comparative safety, effectiveness, and treatment costs of the two first generation direct-acting antiviral agents (DAA), boceprevir...

Descripción completa

Detalles Bibliográficos
Autores principales: Davitkov, Perica, Chandar, Apoorva Krishna, Hirsch, Amy, Compan, Anita, Silveira, Marina G., Anthony, Donald D., Smith, Suzanne, Gideon, Clare, Bonomo, Robert A., Falck-Ytter, Yngve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065164/
https://www.ncbi.nlm.nih.gov/pubmed/27741230
http://dx.doi.org/10.1371/journal.pone.0163945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065164/
https://www.ncbi.nlm.nih.gov/pubmed/27741230
http://dx.doi.org/10.1371/journal.pone.0163945

Ejemplares similares